Baltimore, MD, United States of America

Jolinta Lin

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Imagilin Technology LLC. Active years: 2019-2023.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jolinta Lin

Introduction

Jolinta Lin is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of probiotics, focusing on their applications in treating inflammatory-related diseases. With a total of 3 patents to his name, Lin's work is paving the way for advancements in health and wellness.

Latest Patents

Jolinta Lin's latest patents include innovative methods and compositions for treating diseases characterized by inflammation. One of his notable inventions is a method that involves administering an effective amount of a probiotic to a subject in need, aimed at alleviating inflammation. Additionally, he has developed compositions that combine probiotics with amphipathic substances, enhancing the viability of probiotics when exposed to heat.

Career Highlights

Lin is associated with Imagilin Technology LLC, where he continues to explore and develop probiotic-based solutions. His work is characterized by a commitment to improving health outcomes through innovative scientific approaches.

Collaborations

Jolinta Lin collaborates with Jhy-Jhu Lin, contributing to the advancement of their shared research interests in probiotics and health.

Conclusion

Jolinta Lin's contributions to the field of probiotics and inflammation treatment highlight his role as an innovative inventor. His patents reflect a dedication to improving health through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…